Loading...

Home
ETF
ALLR

ALLR

-

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

$

0.000

0.000(0.000%)

At close

0.000(0.000%)Aft-market

ET

Overview Technical News

Most Trusted AI Platform for Winning Trades

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

Home
Contact
About Us
Press

Markets

Market Analysis
Crypto
Market Movers
Stock Monitor
Economic Calendar
All US Stocks
All Cryptos

AI Strategies

AI Stock Picker
Swing Trading
SwingMax Portfolio
Quant AI Alpha Pick
CoinSwing
Daytrading Center
Crypto Radar
Patterns Detection

Resources

Blog
Tutorial
Help Center
Affiliate Program

Products

Chat With Tia
AI Screener
Backtest Playground
Featured Screeners
AI Earnings Calendar
Thematic Investing
Whales Auto Tracker

Tools

Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator

Features

Explore AI Stock Picker
Master Swing Trading
Follow SwingMax Portfolio
Discover QuantAI Alpha Pick
Follow Whales Auto Tracker
Navigate Daytrading Center
Learn Patterns Detection
Meet Financial AI Agent
Maximize AI Screener
Why Backtesting Playground
Forecast AI Earnings Prediction
Setup Stock Monitor
Deep Dive into Tech Analysis

News

Overview
Top News
Daily Market Brief
Earnings Analysis
Newswire
Stock News
Crypto News
Institution News
Congress News
Monitor News

Compare

TradingView
SeekingAlpha

ALLR News

Allarity Therapeutics Advances Stenoparib with FDA Fast Track Designation

Dec 31 2025Globenewswire

Allarity Therapeutics CEO Letter Highlights Progress Toward Stenoparib FDA Approval

Dec 31 2025Newsfilter

3 Penny Stocks to Keep an Eye On as of August 28, 2025

Aug 28 2025TipRanks

Tuesday's Major Stock Market Highlights: Morning News Summary!

Aug 26 2025TipRanks

Crude Oil Prices Fall 2%; US Durable Goods Orders Decrease in July

Aug 26 2025Benzinga

US Stocks Show Varied Performance; American Woodmark Reports Disappointing Sales

Aug 26 2025Benzinga

What’s Behind the 95% Surge in Allarity Therapeutics Stock (ALLR) Today?

Aug 26 2025TipRanks

Stock Market Update: S&P 500 and Nasdaq Futures Drop— Earnings Reports from Palo Alto, XP, and Allarity Under Scrutiny

Aug 18 2025Benzinga

Stocks to Keep an Eye on This Monday: Palo Alto Networks, Fabrinet, and Two Others

Aug 18 2025Benzinga

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

Aug 15 2025Newsfilter

This MongoDB Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Monday

Jul 28 2025Benzinga

Ascendiant Capital Initiates Coverage On Allarity Therapeutics with Buy Rating, Announces Price Target of $9

Jul 28 2025Benzinga

Allarity Therapeutics Appoints Jeff Ervin To Succeed Alexander Epshinsky As CFO

Jul 07 2025NASDAQ.COM

Allarity Therapeutics Announces Dosing of Second Patient in New Phase 2 Trial of Stenoparib in Advanced Ovarian Cancer

Jun 27 2025Newsfilter

Allarity Teams With IBRI To Advance Dual-Action Cancer Drug Stenoparib

Jun 04 2025NASDAQ.COM

Allarity Therapeutics Provides First Quarter 2025 Update, Highlighting Continued Stenoparib Benefit and Upcoming Trial Enrollment

May 09 2025Newsfilter